hepatitis C

AbbVie Announces Top-line Results from Phase 3 Study of All-Oral Treatment for Hepatitis C in Japan
Yahoo
Sat, 01/31/15 - 10:06 am
AbbVie
Japan
hepatitis C
Abbvie Expects $3B In Hepatitis C Drug Sales And 40% Of Insured Customers
Forbes
Fri, 01/30/15 - 11:18 am
AbbVie
hepatitis C
Viekira Pak
Gilead Sciences, Inc. Continues To Reign Over The Hepatitis C Market
Bidness Etc.
Fri, 01/30/15 - 08:05 am
Gilead Sciences
AbbVie
Harvoni
Sovaldi
hepatitis C
Viekira Pak
Gilead Sciences, Inc. Harvoni Gets Preferred Status From UnitedHealth Group (UNH)
Bidness Etc.
Thu, 01/29/15 - 11:11 am
Gilead Sciences
hepatitis C
United Health
Harvoni
AbbVie
Can Gilead Beat AbbVie At Its Own Game?
Seeking Alpha
Thu, 01/29/15 - 07:28 am
Gilead
AbbVie
hepatitis C
Harvoni
Sovaldi
Viekira Pak
Express Scripts
AbbVie Hepatitis C Drug Will Be Focus of Profit Report — Earnings Preview
WSJ Online
Tue, 01/27/15 - 04:32 pm
AbbVie
earnings
Viekira Pak
hepatitis C
Gilead Sciences, Inc.’s (GILD) Harvoni Prescriptions Drop 1.8%
Bidness Etc.
Mon, 01/26/15 - 11:46 am
Gilead Sciences
Harvoni
hepatitis C
AbbVie
Viekira Pak
Gilead to Allow Generic-Drug Makers to Produce New Hepatitis C Treatment
WSJ Online
Mon, 01/26/15 - 07:52 am
generics
Gilead Sciences
hepatitis C
Sovaldi
India
Patients Blame Cost for Coverage Delay in England of Gilead Drug
WSJ Pharmalot
Fri, 01/23/15 - 08:21 am
UK
Gilead Sciences
patients
Sovaldi
hepatitis C
Express Scripts Targets $150,000 Cancer Drug Prices in 2016 Plan
Bloomberg
Thu, 01/22/15 - 03:53 pm
cancer
Express Scripts
hepatitis C
Gilead, AbbVie Hep C Price Cuts Seen Hitting Sales
Investors.com
Wed, 01/21/15 - 05:42 pm
Gilead Sciences
AbbVie
hepatitis C
drug pricing
Viekira Pak
Harvoni
Sovaldi
Merck Will No Longer Sell its Victrelis Hepatitis C Drug in the U.S.
WSJ Pharmalot
Wed, 01/21/15 - 11:40 am
Merck
Victrelis
hepatitis C
Can Gilead Sciences Beat Hep-C Estimates?
Barron's
Tue, 01/20/15 - 03:59 pm
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
AbbVie Strikes Hepatitis C Discount Deal With AIDS Drug Programs
Bloomberg
Mon, 01/19/15 - 12:06 pm
AbbVie
hepatitis C
AIDS
HIV
Viekira Pak
Gilead's appeal for drug patent in India could see protracted case
The Hindu
Sat, 01/17/15 - 11:05 am
Gilead Sciences
India
hepatitis C
Sovaldi
Aetna backs Gilead's hepatitis C treatment, gets discount
Reuters
Sat, 01/17/15 - 11:03 am
Aetna
Gilead Sciences
hepatitis C
AbbVie
Sovaldi
Harvoni
Viekira Pak
AbbVie’s hepatitis C drug gets European approval for sale
Marketwatch
Fri, 01/16/15 - 08:45 am
AbbVie
hepatitis C
Europe
Viekira Pak
Gilead to appeal India patent ruling on hepatitis C drug
Yahoo/Reuters
Fri, 01/16/15 - 08:11 am
Gilead Sciences
India
patents
Sovaldi
hepatitis C
India Rejects Gilead Patent Bid for Sovaldi Hepatitis C Treatment
WSJ Pharmalot
Thu, 01/15/15 - 08:59 am
India
patents
Gilead Sciences
Sovaldi
hepatitis C
After Roiling Hepatitis Market, Express Scripts Turns to Cholesterol
Bloomberg
Wed, 01/14/15 - 10:08 am
hepatitis C
Express Scripts
Regeneron
Amgen
PCSK9 inhibitor

Pages